2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by METRY, G. Articles by DANIELSON, B. G. Search for Related Content PubMed PubMed Citation Articles by METRY, G. Articles by DANIELSON, B. G.

Effect of Normalization of Hematocrit on Brain Circulation and Metabolism in Hemodialysis Patients

GEORGE METRY^*, BJÖRN WIKSTRÖM^*, SVEN VALIND, BO SANDHAGEN, TORBJÖRN LINDE^*, SOHEIR BESHARA^*, BENGT LNGSTRÖM and BO G. DANIELSON^*

^* Department of Internal Medicine University Hospital, Uppsala, Sweden.
Department of Clinical Physiology, University Hospital, Uppsala, Sweden.
Department of Uppsala University PET Center, University Hospital, Uppsala, Sweden.

Correspondence to Dr. George Metry, Department of Internal Medicine, University Hospital, S-751 85 Uppsala, Sweden. Phone: +46 18 66 43 41; Fax: +46 18 55 11 41; E-mail: george.metry{at}medicin.uu.se

Abstract. Full correction of anemia with recombinant human erythropoietin (rhEPO) has been reported to reduce the risk of cardiovascular morbidity and mortality and improve the quality of life in hemodialysis (HD) patients. Effects of normalization of hematocrit on cerebral blood flow and oxygen metabolism were investigated by positron emission tomography. Regional cerebral blood flow (rCBF), cerebral blood volume (rCBV), oxygen extraction ratio (rOER), and metabolic rate for oxygen (rCMRO₂) were measured in seven HD patients before and after correction of anemia and compared with those in six healthy control subjects. In addition, blood rheology before and on rhEPO therapy was measured in HD patients, which included blood viscosity, plasma viscosity, erythrocyte fluidity, and erythrocyte aggregability. The results showed that plasma viscosity was high (1.51 ± 0.19 mPa · s) and erythrocyte fluidity was low (85.8 ± 4.8 Pa^-1 · s^-1), while whole blood viscosity was within the normal range (3.72 ± 0.38 mPa · s) before rhEPO therapy. After treatment, the hematocrit rose significantly from 29.3 ± 3.3 to 42.4 ± 2.2% (P < 0.001), accompanied by a significant increase in the whole blood viscosity to 4.57 ± 0.16 mPa · s, nonsignificant decrease in erythrocyte fluidity to 79.9 ± 7.4 mPa^-1 · s^-1 and nonsignificant change in plasma viscosity (1.46 ± 1.3 mPa · s). Positron emission tomography measurements revealed that by normalization of hematocrit, rCBF significantly decreased from 65 ± 11 to 48 ± 12 ml/min per 100 cm³ (P < 0.05). However, arterial oxygen content (caO₂) significantly increased from 5.7 ± 0.7 to 8.0 ± 0.4 mmol/L (P < 0.0001), rOER of the hemispheres significantly increased from 44 ± 3 to 51 ± 6% (P < 0.05) and became significantly higher than healthy control subjects (P < 0.05). In addition, rCBV significantly increased from 3.5 ± 0.5 to 4.6 ± 0.6 ml/100 cc brain tissue. The results showed that oxygen supply to the brain tissue increased with normalization of hematocrit, but it was accompanied by increased oxygen extraction in the brain tissue. This may be assumed to be related to the decrease of erythrocyte velocity in the cerebral capillaries as a result of the decreased blood deformability and the increased plasma viscosity.

This article has been cited by other articles:

				G. M. T. Hare, A. K. Y. Tsui, A. T. McLaren, T. E. Ragoonanan, J. Yu, and C. D. Mazer Anemia and Cerebral Outcomes: Many Questions, Fewer Answers Anesth. Analg., October 1, 2008; 107(4): 1356 - 1370. [Abstract] [Full Text] [PDF]

				A. Haktanir, S. Demir, M. Acar, K. Ucok, R. Albayrak, A. Yucel, and C. Gokce Doppler Sonographic Evaluation of Cerebral Blood Flow in Anemia Resulting From Chronic Renal Failure J. Ultrasound Med., July 1, 2005; 24(7): 947 - 952. [Abstract] [Full Text] [PDF]

				T Nagaoka, Y Takeyama, S Kanagawa, K Sakagami, F Mori, and A Yoshida Effect of haemodialysis on retinal circulation in patients with end stage renal disease Br. J. Ophthalmol., August 1, 2004; 88(8): 1026 - 1029. [Abstract] [Full Text] [PDF]

				T. F. Floyd, M. McGarvey, E. A. Ochroch, A. T. Cheung, J. A. Augoustides, J. E. Bavaria, M. A. Acker, A. Pochettino, and J. A. Detre Perioperative changes in cerebral blood flow after cardiac surgery: influence of anemia and aging Ann. Thorac. Surg., December 1, 2003; 76(6): 2037 - 2042. [Abstract] [Full Text] [PDF]

				G. M. T. Hare, C. D. Mazer, W. Mak, R. M. Gorczynski, K. M. Hum, S. Y. Kim, L. Wyard, A. Barr, R. Qu, and A. J. Baker Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression J Appl Physiol, May 1, 2003; 94(5): 2058 - 2067. [Abstract] [Full Text] [PDF]

				A. J. COLLINS, S. LI, W. ST. PETER, J. EBBEN, T. ROBERTS, J. Z. MA, and W. MANNING Death, Hospitalization, and Economic Associations among Incident Hemodialysis Patients with Hematocrit Values of 36 to 39% J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2465 - 2473. [Abstract] [Full Text] [PDF]

				M. Buemi, A. Allegra, F. Corica, F. Floccari, D. D'Avella, C. Aloisi, G. Calapai, G. Iacopino, and N. Frisina Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration Nephrol. Dial. Transplant., March 1, 2000; 15(3): 422 - 423. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673